Other Tests. Promptly submit to the Lender copies of reports of all physical tests at any time made on the Land, the Improvements or the materials to be incorporated into the Improvements and shall, at the Borrower's expense, cause to be made such additional tests from time to time as the Lender may reasonably require after any change in the Premises or receipt by the Lender of any such report.
Other Tests. S Sieve Analysis CD Consolidated-Drained Triaxial C Consolidation H Hydrometer Analysis CU Consolidated-Undrained Triaxial Qu Unconfined Compression γ Unit Weight UU Unconsolidated Undrained Triaxial Ip Point Load Index, Ip(50) Gs Specific Gravity of Soil Particles DS Direct Shear k Laboratory Permeability SOIL DESCRIPTION Terminology describing common soil genesis: Rootmat Vegetation, roots, and xxxx with organic matter and topsoil typically forming a mattress at the ground surface. Topsoil Mixture of soil and humus capable of supporting vegetative growth. Peat A soil composed of vegetable tissue in various stages of decomposition usually with an organic odor, a dark-xxxxx to black color, a spongy consistency, and a texture ranging from fibrous to amorphous. Till Non-stratified glacial deposit which may range from clay to boulders Fill Artificial (man-made) deposits transported and placed on the natural surface of soil or rock. Terminology describing soil structure: Homogeneous The lack of visible bedding and the same appearance and colour throughout Desiccated Having visible signs of weathering by oxidation of clay minerals, shrinking cracks, etc. Fissured Having cracks and hence a blocky structure Stratified Composed of regular alternating successions of different soil types Varved Comprised of regular alternating successions of silt and clay which were transported into freshwater lakes by melt water Layer > 75 mm Seam 2 mm to 75 mm Parting < 2 mm Pocket Small erratic deposit, usually less than 300 mm Lens Lenticular deposit Terminology describing soil types: Soils are described in accordance with the Unified Soil Classification System (USCS) as described in ASTM D2487 and ASTM D2488. This system classifies soil into categories representing the results of laboratory tests to determine the particle-size characteristics, the liquid limit, and the plasticity index. Using this system, soils are assigned a group name (e.g. silty sand) and symbol (e.g. SM). The various groupings of this classification system have been devised to correlate in a general way with the engineering behavior of soils. Laboratory tests are performed on the portion of the sample passing the 75 mm sieve. When laboratory test results indicate that that the soil is close to another classification group, the borderline condition can be indicated with two symbols separated by a slash (e.g. CL/CH). Terminology describing cobbles, boulders, and non-matrix materials: Materials outside of the ...
Other Tests. Prior to achieving Project COD, Buyer shall have the right to request that Seller conduct, or cause to be conducted, a Ramp Rate Test, a Duty Cycle Test and/or a Roundtrip Efficiency Test in accordance with NYISO Rules and APPENDIX 3
Other Tests. The Independent Engineer may require the Concessionaire to carry out or cause to be carried additional Tests, in accordance with Good Industry Practice, for determining the compliance of the Project with Specifications and Standards.
Other Tests a.(i) If the work cubes do not give the required strengths, the Engineer reserves the right to ask the Contractor to dismantle such portions of the work which in his opinion are unacceptable and re-do the work to the standard required at the Contractor's cost.
Other Tests. Abbott hereby grants to NeoGenomics a first right to develop two (2) additional LDTs using Abbott ASRs, other Xxxxxx products and/or Abbott Intellectual Property relating to the disease states identified in Exhibit G (each, an “Additional Test”). NeoGenomics will notify Xxxxxx in writing within ninety (90) days after the Effective Date if it elects to commence negotiations relating to the first Additional Test described in Exhibit G (the “Initial Decision Period”). Xxxxxx will notify NeoGenomics in writing when Xxxxxx believes that its products or intellectual property relating to other potential Additional Tests are ready to be commercialized, which notice will describe the applicable products and/or intellectual property in reasonable detail; provided, that Xxxxxx will not deliver such notice to NeoGenomics prior to the earlier of June 30, 2010, or the date which is thirty (30) days after the parties have executed a Subsequent Development Agreement (as defined below) regarding the first Additional Test described in Exhibit G. If NeoGenomics elects to commence negotiations relating to an Additional Test other than the first Additional Test described in Exhibit G, it will so notify Xxxxxx in writing within thirty (30) days after its receipt of notice from Xxxxxx relating to such Additional Test (the “Additional Decision Period” and together with the Initial Decision Period, each a “Decision Period”). Subject to the terms hereof, until the expiration of both the applicable Decision Period and Negotiation Period with respect to an Additional Test, Xxxxxx shall not pursue negotiations with, nor negotiate with or furnish information regarding such Additional Test to any Third Party (except academic collaborators for research purposes). Each date on which NeoGenomics provides written notice of its desire to commence negotiations regarding an Additional Test is referred to herein as a “Commencement Date.” For a period of ninety (90) days following a Commencement Date (an “Initial Negotiation Period”), the parties will negotiate exclusively and in good faith to enter into a definitive agreement (a “Subsequent Development Agreement”) providing for the development and commercialization of the applicable Additional Test; provided, however, that neither party will be obligated to enter into such a Subsequent Development Agreement except on mutually acceptable terms and conditions. The parties intend and agree that each Subsequent Development Agreement shall be negoti...
Other Tests. All custodians shall also take such tests and provide such reports as to their health (e.g., freedom from tuberculosis) as is required by statutes, rules or regulations promulgated by the State of Minnesota or any agency or department thereof.
Other Tests. In the event that a member of the hospital’s work force sustains a bodily fluid exposure during the course of my treatment, I consent to HIV testing and authorize the hospital to release the result of this said test to me, the exposed healthcare employee, and my physician. I understand that I have the right to refuse testing without penalty. I authorize I do not authorize Interpreter: If interpreter used, please complete the following: Remote In-person Interpreter ID Number (if phone/video interpreter used): Date: Time: Printed Name of Interpreter: I AGREE TO THE ITEMS STATED ABOVE AND CERTIFY THAT ALL INFORMATION PROVIDED INCLUDING INSURANCE IS ACCURATE AND CORRECT TO THE BEST OF MY KNOWLEDGE. NO CHANGES TO THIS FORM WILL BE ACCEPTED. Date: Time: Patient Signature: For health care agent / guardian / surrogate / parent / spouse (circle one), I, (print name), am the representative for the patient. Date: Time: Representative’s signature: Relationship to Patient: Date: Time: XXXXX XXXXXXX NOTICES Pathology: Xxxxx Xxxxxxx may dispose of any tissue or parts that are removed during a procedure; may retain, preserve, use, and share these tissues, parts or related information for internal educational and quality improvement purposes without my permission (even when these tissues, parts or related information identify me); and may use or share tissues, parts or related information that identifies me for research with my permission or with the approval of a review board governed by federal laws protecting these activities. If tissues, parts or related information do not identify me, Xxxxx Xxxxxxx may use them for scientific (research) purposes without my permission or action by a review board.
Other Tests. Static Reservoir Pressure - Other tests as deemed to be necessary by the Lessor. After commencement of commercial production from each of such xxxxx, Lessee shall annually, or more frequently if requested by the Lessor, determine static reservoir pressure and complete any other tests as specified by the Lessor.
Other Tests. The following additional tests may be conducted at the discretion of Milk Department and where a result is outside the acceptable level an investigation may occur and collection may be suspended. A test for Colostrum may be conducted and a level of 0.3% or less is considered acceptable. A test of Freezing Point may be conducted and a result of < 0.512 ºC is considered acceptable. A test of Acidity may be conducted and a result of < 0.14% is considered acceptable. A test of pH may be conducted and a result of > 6.6 is considered acceptable. A test for Aflatoxin may be conducted and a result of < 0.50 ppb aflatoxin M1 is considered acceptable.
